Detalhe da pesquisa
1.
Buspirone and Zolmitriptan Combination for Dyskinesia: A Randomized, Controlled, Crossover Study.
Mov Disord
; 39(3): 613-618, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38314643
2.
Diagnostic metabolomic profiling of Parkinson's disease biospecimens.
Neurobiol Dis
; 177: 105962, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36563791
3.
Application of Neuromelanin MR Imaging in Parkinson Disease.
J Magn Reson Imaging
; 57(2): 337-352, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36017746
4.
Inhaled levodopa for threatening impending OFF episodes in managing Parkinson's disease.
J Neural Transm (Vienna)
; 130(6): 821-826, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37087697
5.
Are Parkinson's disease patients referred too late for device-aided therapies and how can better informed and earlier referrals be encouraged?
J Neural Transm (Vienna)
; 130(11): 1405-1409, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37526767
6.
Focused ultrasound opening of the blood-brain barrier for treatment of Parkinson's disease.
Mov Disord
; 34(9): 1274-1278, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31136023
7.
Response to "Neuromelanin? MRI of Noradrenergic and Dopaminergic Neurons".
J Magn Reson Imaging
; 58(1): 326-327, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36408902
8.
Prospective evaluation of pulmonary function in Parkinson's disease patients with motor fluctuations.
Int J Neurosci
; 127(3): 276-284, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27345931
9.
A randomized trial of inhaled levodopa (CVT-301) for motor fluctuations in Parkinson's disease.
Mov Disord
; 31(9): 1356-65, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27090868
10.
CSF Nrf2 and HSPA8 in Parkinson's disease patients with and without LRRK2 gene mutations.
J Neural Transm (Vienna)
; 123(3): 179-87, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26526034
11.
Levodopa therapy for Parkinson's disease: Pharmacokinetics and pharmacodynamics.
Mov Disord
; 30(1): 64-72, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25449210
12.
Norepinephrine deficiency in Parkinson's disease: the case for noradrenergic enhancement.
Mov Disord
; 29(14): 1710-9, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25297066
13.
Double-blind study of the actively transported levodopa prodrug XP21279 in Parkinson's disease.
Mov Disord
; 29(1): 75-82, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24339234
14.
Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial.
Lancet Neurol
; 23(5): 465-476, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38499015
15.
Comment on 'Distinct Metabolomic Signature in Cerebrospinal Fluid in Early Parkinson's Disease' by Hiller et al.
Mov Disord
; 33(5): 855, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29722456
16.
3-hydroxykynurenine and other Parkinson's disease biomarkers discovered by metabolomic analysis.
Mov Disord
; 28(12): 1653-60, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23873789
17.
Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson's disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER.
J Neural Transm (Vienna)
; 120(7): 1069-81, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23208198
18.
Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin(®)) injections in blepharospasm.
J Neural Transm (Vienna)
; 120(9): 1345-53, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23435927
19.
Drugs to the Rescue: Comparison of On-Demand Therapies for OFF Symptoms in Parkinson's Disease.
J Parkinsons Dis
; 13(4): 441-451, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37182902
20.
The Clinical Development of Levodopa Inhalation Powder.
Clin Neuropharmacol
; 46(2): 66-78, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36715241